Diabetes and Endocrine Disorders

Welcome Message

We are delighted to welcome you to the 28th World Congress on Diabetes and Endocrine Disorders, taking place on June 25–26, 2026, in Paris, France.

This prestigious global congress brings together leading endocrinologists, diabetologists, researchers, clinicians, healthcare professionals, and industry experts to exchange knowledge, share cutting-edge research, and discuss the latest advancements in diabetes care and endocrine science. The scientific program will feature insightful keynote lectures, plenary sessions, interactive workshops, and oral and poster presentations covering innovations in prevention, diagnosis, treatment, and management of diabetes and endocrine disorders.

We look forward to welcoming you to Paris for an inspiring and productive congress.

About the Conference

The 28th World Congress on Diabetes and Endocrine Disorders, scheduled for June 25–26, 2026, in Paris, France, is a premier international gathering that brings together endocrinologists, diabetologists, researchers, clinicians, healthcare professionals, and industry experts to share knowledge and advancements in diabetes and endocrine science. The congress will feature keynote lectures, plenary sessions, workshops, and oral and poster presentations covering the latest research, innovative therapies, and emerging technologies in the prevention, diagnosis, and management of diabetes and endocrine disorders, while providing valuable opportunities for global networking, collaboration, and professional development in the dynamic and culturally rich city of Paris.

Event Highlights

1. Plenary & Keynote Talks by renowned experts in diabetes and endocrinology.
2. Scientific Sessions on advances in diabetes care, endocrine disorders, and metabolic health.
3. Oral & Poster Presentations featuring latest research findings.
4. Young Researchers Forum promoting early-career scientists and clinicians.

Why to Attend?

• Stay informed about the latest advancements, emerging trends, and breakthrough research in diabetes and endocrine disorders.
• Learn from globally recognized experts through keynote lectures and scientific sessions.
• Present your research to an international audience and gain valuable feedback from leading clinicians and researchers.
• Engage in interactive discussions with endocrinologists, diabetologists, healthcare professionals, and industry leaders.
• Explore innovative diagnostic tools, therapies, and technologies transforming diabetes and endocrine care.
• Build strong professional networks and foster collaborations across academia, clinical practice, and industry.

Target Audience

• Endocrinologists and Diabetologists
• Physicians and Clinical Practitioners
• Researchers and Academicians in Endocrinology and Metabolic Sciences
• Diabetes Educators and Nurse Practitioners
• Nutritionists and Dietitians
• Pediatric and Geriatric Endocrinologists
• Epidemiologists and Public Health Professionals
• Clinical Laboratory Professionals
• Pharmacologists and Drug Development Scientists
• Medical and Graduate Students, Postdoctoral Fellows
• Industry Professionals, Biotechnology and Pharmaceutical Experts
• Healthcare Administrators and Policy Makers

Benefits of Participation

• Build strong academic, clinical, and professional collaborations with global experts in diabetes and endocrinology.
• Gain in-depth insights into the latest advancements in diabetes management, endocrine research, and metabolic health.
• Collaborate with leading clinicians, researchers, and innovators shaping the future of endocrine care.
• Participate in high-impact networking sessions with healthcare professionals, researchers, and industry representatives.
• Engage in evidence-based discussions with experts from academia, clinical practice, and healthcare industries.
• Explore specialized exhibition areas showcasing advanced diagnostics, therapeutic solutions, medical devices, and digital health technologies for diabetes and endocrine disorders.
• Experience a dynamic learning environment with professionals dedicated to improving endocrine and metabolic health worldwide.
• Take advantage of interactive workshops, panel discussions, and case-based learning sessions.
• Attend focused sessions highlighting breakthrough research, novel therapies, and emerging technologies in endocrinology.
• Discover new treatment approaches, clinical tools, and healthcare innovations supporting diabetes and endocrine care.

Benefits for Young Scientists

• An excellent platform to present research through oral and poster presentations at an international congress.
• Opportunities to exchange ideas with renowned endocrinologists, diabetologists, and research mentors.
• Recognition through awards, certificates, and mementos for outstanding research contributions.
• Access to expert guidance, constructive feedback, and career-oriented sessions.
• A supportive and collaborative environment to build professional networks with fellow young researchers.
• Inspiration and motivation to enhance research potential and make meaningful contributions to diabetes and endocrine science.

Scientific Tracks and Sessions:

Track 1: Diabetes Type 1 & Type 2

This track focuses on the fundamental and clinical aspects of Type 1 and Type 2 diabetes, covering disease pathophysiology, genetic and environmental risk factors, early diagnosis, and long-term management strategies. Discussions will highlight advances in insulin therapy, oral and injectable antidiabetic agents, lifestyle interventions, and patient-centered care approaches. The session also addresses prevention strategies, glycemic control, complication management, and emerging technologies that improve outcomes and quality of life for people living with diabetes.

Type 1 Diabetes | Type 2 Diabetes | Insulin Therapy | Glycemic Control | Insulin Resistance | Beta-Cell Dysfunction | Diabetes Diagnosis | Lifestyle Interventions | Antidiabetic Drugs | Continuous Glucose Monitoring | Diabetes Complications

Track 2: Genomics in Endocrinology

This session explores the role of genomics and precision medicine in understanding, diagnosing, and treating endocrine disorders. It covers genetic testing, biomarker discovery, gene–disease associations, pharmacogenomics, and personalized therapeutic strategies to optimize patient care. The session emphasizes how genomic insights can guide individualized treatment plans and improve outcomes in diabetes, thyroid disorders, adrenal and pituitary diseases, and other hormonal conditions.

Endocrine Genomics | Precision Medicine | Genetic Testing | Biomarkers | Gene-Disease Associations | Pharmacogenomics | Personalized Therapy | Diabetes Genetics | Thyroid Genetics | Adrenal & Pituitary Disorders | Hereditary Endocrine Disorders

Track 3: Obesity, Diet & Lifestyle

This track focuses on the role of nutrition, diet, and lifestyle interventions in the prevention and management of obesity and metabolic disorders. Sessions will cover dietary strategies, weight management, physical activity, behavioral therapy, and integrative approaches to improve metabolic health and reduce the risk of diabetes and endocrine complications.

Obesity Management | Nutrition Therapy | Diet Planning | Lifestyle Interventions | Weight Management | Physical Activity | Behavioral Therapy | Metabolic Health | Diabetes Prevention | Endocrine Health | Healthy Lifestyle

Track 4: Technology in Diabetes Care

This track explores the latest technological advancements in diabetes and endocrine care, including continuous glucose monitoring (CGM), insulin pumps, artificial pancreas systems, telemedicine, mobile health applications, and digital tools for patient management. Discussions will focus on how these innovations improve disease monitoring, enhance treatment adherence, and optimize patient outcomes.

Diabetes Technology | Continuous Glucose Monitoring | Insulin Pumps | Artificial Pancreas | Telemedicine | Mobile Health Apps | Digital Health | Remote Patient Monitoring | Endocrine Care Tools | Health Informatics | Smart Diabetes Management

Track 5: Neuroendocrine Disorders

This track focuses on disorders arising from dysfunction of the neuroendocrine system, which integrates the nervous and endocrine systems to regulate growth, metabolism, reproduction, stress response, and homeostasis. Sessions will address the pathophysiology, diagnosis, and management of neuroendocrine conditions, including pituitary adenomas, neuroendocrine tumors, hypothalamic disorders, and hormone-secreting neoplasms. Emphasis will be placed on advances in molecular diagnostics, imaging techniques, and personalized treatment approaches, as well as multidisciplinary strategies involving endocrinology, oncology, neurology, and surgery to improve patient outcomes.

Neuroendocrine Disorders | Pituitary Adenomas | Neuroendocrine Tumors (NETs) | Hypothalamic Dysfunction | Hormone Secretion Disorders | Endocrine Neoplasia | Molecular Diagnostics | Functional Imaging | Precision Endocrinology | Targeted Therapies

Track 6: Insulin Resistance & Prediabetes

This track focuses on the early stages of metabolic dysfunction, including insulin resistance and prediabetes, which are key risk factors for Type 2 diabetes and cardiovascular disease. Sessions will cover pathophysiology, diagnostic markers, lifestyle and pharmacological interventions, prevention strategies, and risk assessment to halt progression to diabetes and associated endocrine disorders.

Insulin Resistance | Prediabetes | Metabolic Syndrome | Glucose Intolerance | Risk Assessment | Early Intervention | Lifestyle Management | Diet & Exercise | Cardiometabolic Risk | Diabetes Prevention | Endocrine Disorders

Track 7: Nursing & Endocrine Care

This track focuses on the early stages of metabolic dysfunction, including insulin resistance and prediabetes, which are key risk factors for Type 2 diabetes and cardiovascular disease. Sessions will cover pathophysiology, diagnostic markers, lifestyle and pharmacological interventions, prevention strategies, and risk assessment to halt progression to diabetes and associated endocrine disorders.

Diabetes Nursing | Patient-Centered Care | Diabetes Education | Self-Management | Clinical Nursing Practices | Patient Engagement | Treatment Adherence | Endocrine Nursing | Health Outcomes | Chronic Disease Management | Supportive Care

Track 8: Pharmacotherapy in Diabetes

This track focuses on the latest developments in drug therapies for diabetes management. It covers oral hypoglycemic agents, insulin formulations, GLP-1 receptor agonists, SGLT2 inhibitors, combination therapies, personalized pharmacological approaches, and strategies to optimize glycemic control and prevent complications in diabetic patients.

Diabetes Medications | Antidiabetic Drugs | Insulin Therapy | GLP-1 Agonists | SGLT2 Inhibitors | Oral Hypoglycemics | Combination Therapy | Glycemic Control | Personalized Medicine | Diabetes Management | Pharmacological Strategies

Track 9: Dermatology in Diabetes

This track explores the skin-related complications and manifestations associated with diabetes, including infections, diabetic dermopathy, necrobiosis lipoidica, fungal infections, ulcers, and delayed wound healing. Sessions will cover early recognition, diagnosis, management strategies, and preventive approaches to improve patient outcomes and quality of life.

Diabetic Dermopathy | Skin Complications | Fungal Infections | Ulcers & Wound Healing | Necrobiosis Lipoidica | Cutaneous Manifestations | Diabetes-Related Skin Disorders | Early Diagnosis | Management Strategies | Preventive Care 

Track 10: Endocrine Oncology

This track focuses on hormone-related cancers, including thyroid, adrenal, and pituitary tumors. Sessions cover pathophysiology, early detection, diagnostic techniques, molecular profiling, targeted therapies, and advances in personalized treatment strategies. Emphasis will be placed on improving patient outcomes, clinical management, and emerging research in endocrine malignancies.

Endocrine Tumors | Thyroid Cancer | Adrenal Cancer | Pituitary Tumors | Hormone-Related Malignancies | Targeted Therapy | Molecular Profiling | Personalized Medicine | Oncology Endocrinology | Cancer Diagnosis | Tumor Management

Track 11: Clinical Endocrine Research

This track highlights the latest advances in clinical and translational research in endocrinology and diabetes. It covers clinical trials, biomarker discovery, experimental therapies, patient-centered studies, and strategies to translate laboratory findings into effective treatments for endocrine and metabolic disorders.

Clinical Trials | Translational Research | Endocrine Biomarkers | Experimental Therapies | Patient-Centered Studies | Diabetes Research | Metabolic Disorders | Molecular Endocrinology | Therapeutic Development | Bench-to-Bedside

Track 12: Cardiometabolic Disorders

This track explores the interconnection between cardiovascular diseases, diabetes, obesity, and metabolic syndrome. Sessions will cover risk factors, pathophysiology, preventive strategies, lifestyle interventions, pharmacological treatments, and integrated approaches to reduce cardiometabolic complications and improve overall patient outcomes.

Cardiovascular Risk | Metabolic Syndrome | Obesity | Hypertension | Dyslipidemia | Type 2 Diabetes | Heart Disease | Insulin Resistance | Lifestyle Interventions | Preventive Care | Endocrine-Cardiac Health | Patient Outcomes

Track 13: Metabolic & Hormone Regulation

This track focuses on the molecular mechanisms and physiological processes governing hormonal regulation and metabolic pathways. Sessions will explore insulin signaling, glucose and lipid metabolism, hormonal feedback loops, endocrine cross-talk, and how disruptions contribute to diabetes, obesity, and other metabolic disorders. Insights into therapeutic targets and metabolic modulation strategies will also be discussed.

Hormonal Regulation | Insulin Signaling | Glucose Metabolism | Lipid Metabolism | Endocrine Feedback Loops | Metabolic Pathways | Hormone-Metabolism Interactions | Diabetes Mechanisms | Obesity | Metabolic Disorders | Therapeutic Targets

Track 14: Diabetic Retinopathy

This track focuses on the ocular complications of diabetes, including the pathophysiology, early detection, screening protocols, and management strategies for diabetic retinopathy. Sessions will cover preventive care, laser and pharmacological therapies, surgical interventions, and the role of advanced imaging and digital tools in preserving vision and improving patient outcomes.

Diabetic Retinopathy | Eye Complications in Diabetes | Vision Loss | Ophthalmology | Retinal Screening | Laser Therapy | Anti-VEGF Therapy | Preventive Care | Advanced Imaging | Diabetes-Related Eye Disorders | Patient Outcomes

Track 15: Public Health & Diabetes

This track addresses the global impact of diabetes and endocrine disorders from a public health perspective. Sessions will cover epidemiology, prevention programs, healthcare policies, population-based interventions, health disparities, and strategies to reduce the burden of diabetes worldwide. Emphasis will be placed on community health initiatives, awareness campaigns, and evidence-based approaches to improve outcomes and accessibility of care.

Diabetes Epidemiology | Public Health | Global Diabetes Burden | Prevention Programs | Healthcare Policy | Population Health | Health Disparities | Community Health | Awareness Campaigns | Chronic Disease Management | Endocrine Health

Track 16: Regenerative Endocrinology

This track focuses on innovative and emerging therapeutic approaches in diabetes and endocrine disorders, including stem cell therapy, gene therapy, tissue engineering, and regenerative medicine. Sessions will explore how these advanced strategies aim to restore normal endocrine function, promote beta-cell regeneration, and offer personalized treatment options for patients with chronic metabolic and hormonal conditions.

Regenerative Medicine | Stem Cell Therapy | Gene Therapy | Beta-Cell Regeneration | Tissue Engineering | Novel Endocrine Therapies | Personalized Medicine | Diabetes Treatment Innovations | Hormonal Restoration | Emerging Therapeutics

Track 17: Immunoendocrinology

This track explores the interplay between the immune system and endocrine disorders, focusing on autoimmune diseases such as Type 1 diabetes, Hashimoto’s thyroiditis, Addison’s disease, and other immune-mediated hormonal conditions. Sessions will cover pathophysiology, diagnostic markers, immunotherapy approaches, and strategies for early detection, management, and prevention of autoimmune endocrine disorders.

Autoimmune Endocrine Disorders | Type 1 Diabetes | Hashimoto’s Thyroiditis | Addison’s Disease | Immune-Endocrine Interactions | Autoantibodies | Immunotherapy | Endocrine Autoimmunity | Hormonal Imbalance | Early Detection

Track 18: Diabetes Glycemic Management

This track focuses on the strategies to maintain optimal blood glucose levels and prevent acute complications in diabetes. Sessions will cover monitoring techniques, insulin and oral therapy adjustments, dietary and lifestyle interventions, prevention and management of hypoglycemia and hyperglycemia, and individualized care plans to improve long-term patient outcomes.

Glycemic Control | Blood Glucose Monitoring | Hypoglycemia Management | Hyperglycemia Management | Insulin Therapy | Oral Antidiabetic Agents | Lifestyle Intervention | Dietary Management | Personalized Care | Diabetes Complications Prevention

Track 19: Diabetes in Pregnancy

This track focuses on gestational diabetes and diabetes management during pregnancy, addressing maternal and fetal health. Sessions will cover screening, diagnosis, glycemic control, nutritional guidance, insulin therapy, risk management, and strategies to prevent complications for both mother and baby.

Gestational Diabetes | Maternal Diabetes | Pregnancy Complications | Fetal Health | Glycemic Control | Insulin Therapy | Nutritional Guidance | Diabetes Screening | Risk Management | Maternal-Fetal Care | Endocrine Pregnancy Care

Track 20: Psychosocial Diabetes Care

This track focuses on the psychological and emotional aspects of living with diabetes. Sessions will cover stress management, depression, anxiety, behavioral therapy, patient adherence, coping strategies, and interventions to improve quality of life and overall wellbeing for individuals with diabetes.

Diabetes & Mental Health | Psychosocial Support | Depression | Anxiety | Stress Management | Behavioral Therapy | Patient Adherence | Emotional Wellbeing | Coping Strategies | Quality of Life | Diabetes Self-Management

Market Analysis Report

The global diabetes and endocrine care market remains robust in 2026, with the diabetes diagnostics market expected to reach around USD?38?billion, growing at a CAGR of approximately 8% driven by rising prevalence and adoption of advanced technologies such as continuous glucose monitoring and AI-enabled tools The global diabetes drugs market is projected at about USD?66?billion in 2026, with a forecasted CAGR of roughly 5–5.5% as demand for insulin therapies, oral antidiabetics, and novel agents increases alongside expanding patient populations. Meanwhile, the broader endocrinology drugs market is estimated at nearly USD?36?billion in 2026, with a strong growth outlook driven by rising incidence of hormonal disorders and advances in targeted therapies (CAGR ~8%+ through the decade). These trends highlight the significant economic scale and innovation momentum in diabetes and endocrine care, underscoring strong demand for clinical education, research exchange, technology showcases, and policy dialogue at international conferences in this field.

Past Conference Report

The 28th World Congress on Diabetes and Endocrine Disorders, held on June 25–26, 2026, in Paris, France, built on the success of the 27th edition in Dubai, bringing together over 1,200 participants from 50+ countries, including endocrinologists, diabetologists, researchers, and healthcare professionals. The congress featured plenary and keynote sessions by global experts, 17 thematic tracks, and 200+ research presentations, covering Type 1 & Type 2 diabetes, gestational and pediatric diabetes, metabolic syndrome, thyroid and adrenal disorders, rare endocrine diseases, and psychosocial care. Attendees explored the latest therapeutics, digital health tools, diagnostics, and wearable technologies through exhibitions, workshops, and panel discussions. The Young Researchers Forum highlighted emerging talent, while interactive sessions fostered collaboration, knowledge exchange, and strategies to improve patient care worldwide, making the Paris congress a premier platform for innovation and global networking in diabetes and endocrine disorders.